Skip to main content
Unknown status

Sorafenib in Previously Treated Malignant Mesothelioma

By April 24, 2017No Comments

Condition

Mesothelioma

Estimated Enrollment: 54

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: 2007-005091-13

Study First Received: November 19, 2008

Last Updated: August 3, 2009

Estimated Primary Completion Date: December 2009

 

Primary Outcome Measures:

Progression-free survival|Response rate as assessed with CT scan|Overall survival|Change in FDG-PET avidity

Sponsors and Collaborators:

King’s College London|Bayer

Website Link: https://ClinicalTrials.gov/show/NCT00794859

Leave a Reply